Other functions - cancer prevention agent development program: early phase clinical research

Ended Awarded Last action

Contract number
HHSN261201200034I
Awardee
Awarding agency
Task orders
14 $17,136,785 obligated

Award facts

Combined order value
  • $17,136,785 Current, with exercised options
  • $18,827,655 Potential, with all options
Last date to order 100% complete
IDV ceiling 20% used
$85,000,000.00
Maximum order
$50,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Other functions - cancer prevention agent development program: early phase clinical research 75N91019F00129 National Cancer Institute (NIH) $2,048,502
Pilot study of denosumab in BRCA1/2 mutation carriers scheduled for risk-reducing salpingo-oopherectomy HHSN26100013 National Cancer Institute (NIH) $262,986
A phase i dose escalation study of topical bexarotene in women at high risk for breast cancer HHSN26100012 National Cancer Institute (NIH) $556,189
A randomized, double-blind, placebo-controlled study of 4-hydroxytamoxifen topical GEL in women with mammographically… HHSN26100011 National Cancer Institute (NIH) $2,186,265
Core infrastructure support HHSN26100010 National Cancer Institute (NIH) $4,248,161
Vadis trial: phase II trial of E75 peptide vaccine in women with dcis of the breast HHSN26100009 National Cancer Institute (NIH) $501,636
Alternative dosing of exemestane in postmenopausal women with stage 0-II ER-positive breast cancer: a randomized… HHSN26100008 National Cancer Institute (NIH) $1,581,195
Effect of aspirin on biomarkers of barrett's esophagus after successful eradication of barrett's esophagus with… HHSN26100007 National Cancer Institute (NIH) $846,289
Core infrastructure support HHSN26100005 National Cancer Institute (NIH) $725,738
A multicenter phase II study of docosahexaenoic acid (DHA) in patients with a history of breast cancer, premalignant… HHSN26100006 National Cancer Institute (NIH) $716,626
Contractor: core infrastructure support HHSN26100004 National Cancer Institute (NIH) $627,582
A phase IB biomarker trial of naproxen in patients at risk for DNA mismatch repair deficient colorectal cancer… HHSN26100003 National Cancer Institute (NIH) $1,340,619
A randomized phase II trial of low dose aspirin versus placebo in high risk individuals with CT screen detected lung… HHSN26100002 National Cancer Institute (NIH) $999,843
Other functions - cancer prevention agent development program: early phase clinical research - core infrastructure… HHSN26100001 National Cancer Institute (NIH) $495,153
Show all 14

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Exercise an Option 5 $0
Exercise an Option 4 $0
Supplemental Agreement for work within scope 3 $0
Other Administrative Action 2 $0
Change Order 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201200034I?

HHSN261201200034I was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on September 24, 2012.

How much is contract HHSN261201200034I worth?

Orders under HHSN261201200034I have obligated $17,136,785. Their combined potential value, with all options, is $18,827,655. HHSN261201200034I's own ceiling is $85,000,000. A single order can be worth up to $50,000,000.

How many orders have been placed under contract HHSN261201200034I?

14 orders have been placed under HHSN261201200034I, the latest on September 10, 2019.

Who can order from contract HHSN261201200034I?

HHSN261201200034I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201200034I part of a contract vehicle?

Yes. HHSN261201200034I is part of Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN261201200034I competed?

The extent of competition for HHSN261201200034I was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login